**US9168961038 - Common Stock - Premarket: 2.88 +0.04 (+1.41%)**

We assign a fundamental rating of **5** out of 10 to **UEC**. **UEC** was compared to 384 industry peers in the **Oil, Gas & Consumable Fuels** industry. **UEC** has a great financial health rating, but its profitability evaluates not so good. **UEC** is valued quite expensive, but it does show an excellent growth.

The Piotroski-F score of **UEC** is **5.00**. This is a neutral score and indicates average health and profitability for **UEC**.

ROA (2.72%) VS Industry: 14% outperformed.

0.06

1,708.00

ROE (3.19%) VS Industry: 6% outperformed.

0.30

19,161.80

Profit Margin (17.31%) VS Industry: 34% outperformed.

0.07

334.14

With a price book ratio of **1.71**, **UEC** is valued correctly.

The **Price/Earnings Ratio** is negative for **UEC**. In the last year negative earnings were reported.

With a **Forward Price/Earnings Ratio** of **80.34**, **UEC** is valued very expensively.

When comparing the price book ratio of **UEC** to the average industry price book ratio of 1.45, **UEC** is valued more expensive than its industry peers.

Price/Book (1.71) VS Industry: 40% outperformed.

4,038.18

0.04

The **Earnings Per Share** has grown by an impressive **204.06%** over the past year.

The **Earnings Per Share** is expected to grow by **68.49%** on average over the next 5 years. This is a very strong growth

Looking at the last year, **UEC** shows a very strong growth in **Revenue**. The Revenue has grown by **773.27%**.

Based on estimates for the next 5 years, **UEC** will show a very strong growth in **Revenue**. The Revenue will grow by **52.38%** on average per year.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | 204.06% | -1% | 94.1% | 116.02% | 68.49% |

Revenue | N/A | N/A | 773.27% | 266.95% | 84.21% | 75.79% | 52.38% |

The Quick Ratio of **UEC** is much better than the industry average of **1.02**.

With a Debt to Equity ratio of **0.00**, **UEC** is doing better than the averages in the industry. The industry average is at **0.25**.

Debt/Equity (0) VS Industry: 80% outperformed.

78.08

0.00

Quick Ratio (2.83) VS Industry: 79% outperformed.

0.00

279.52

Current Ratio (4.46) VS Industry: 85% outperformed.

0.00

279.52

Altman-Z (5.57) VS Industry: 86% outperformed.

-283,883.16

804.85

No dividends for **UEC**!.

NYSEARCA:UEC (3/28/2023, 7:04:00 PM)**+0.02 (+0.71%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)03-15 2023-03-15/bmo

Earnings (Next)06-12 2023-06-12/bmo

Inst Owners45.38%

Inst Owner Change14.8%

Ins Owners1.65%

Ins Owner Change2.26%

Market Cap1.07B

Analysts84.44

Price Target7.01 (146.83%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)0.99%

Min EPS beat(2)0.99%

Max EPS beat(2)0.99%

EPS beat(4)3

Avg EPS beat(4)100%

Min EPS beat(4)0.99%

Max EPS beat(4)298.02%

Revenue beat(2)1

Avg Revenue beat(2)88.32%

Min Revenue beat(2)88.32%

Max Revenue beat(2)88.32%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)52.94%

EPS NY rev (3m)52.94%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)215.51%

Revenue NY rev (3m)215.51%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 80.34 | ||

P/S | 9.25 | ||

P/FCF | 63.18 | ||

P/OCF | 58.27 | ||

P/B | 1.71 | ||

P/tB | 17.25 | ||

EV/EBITDA | N/A |

EPS(TTM)-0.02

EYN/A

EPS(NY)0.04

Fwd EY1.24%

FCF(TTM)0.04

FCFY1.58%

OCF(TTM)0.05

OCFY1.72%

SpS0.31

BVpS1.66

TBVpS0.16

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.72% | ||

ROE | 3.19% | ||

ROIC | N/A | ||

ROICexc | N/A | ||

ROICexgc | N/A | ||

OM | N/A | ||

PM | 17.31% | ||

GM | 27.59% |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.16

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Debt/EBITDA | N/A | ||

Cap/Depr | 101.42% | ||

Profit Quality | 84.64% | ||

Current Ratio | 4.46 | ||

Quick Ratio | 2.83 | ||

Altman-Z | 5.57 |

F-Score5

WACC10.51%

ROIC/WACCN/A

Cap/Depr(3y)66.16%

Cap/Depr(5y)279.15%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y204.06%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q241.74%

EPS Next Y-1%

EPS Next 2Y94.1%

EPS Next 3Y116.02%

EPS Next 5Y68.49%

Revenue growth 1Y773.27%

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2Q263.36%

Revenue Next Year266.95%

Revenue Next 2Y84.21%

Revenue Next 3Y75.79%

Revenue Next 5Y52.38%

EBIT growth 1Y80.08%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year94.96%

EBIT Next 3Y47.64%

EBIT Next 5Y51.17%

FCF growth 1Y249.95%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y267.43%

OCF growth 3YN/A

OCF growth 5YN/A

*Find stocks with similar Fundamental rating on the USA*

*Find more growth stocks the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*